Boston Therapeutics Awarded Key European Patent
The patent has claims for the composition of matter in the use of specific low and high molecular weight mannan polysaccharides to inhibit the … publicly update any forward-looking statements contained herein, whether as a result of new information, future events or otherwise, except as required by law.